BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1943533)

  • 21. Subdermal progestin implant contraception.
    Darney PD
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
    Coukell AJ; Balfour JA
    Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovations in contraception: the Norplant system.
    Klaisle CM; Wysocki S
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):267-79. PubMed ID: 1596435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norplant: what health educators need to know.
    Ogletree RJ; Welshimer KJ
    J Health Educ; 1994; 25(4):230-3. PubMed ID: 12288963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norplant implants in the UK: first year continuation and removals.
    Peers T; Stevens JE; Graham J; Davey A
    Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NORPLANT: levonorgestrel-releasing contraceptive implant.
    Croxatto HB
    Ann Med; 1993 Apr; 25(2):155-60. PubMed ID: 8489753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability of Norplant-2 rods as a method of family planning.
    Singh K; Viegas OA; Ratnam SS
    Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Norplant implants in a New York City clinic population.
    Gerber S; Westhoff C; Lopez M; Gordon L
    Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of Norplant implants for fertility regulation in Singapore.
    Singh K; Viegas OA; Fong YF; Ratnam SS
    Contraception; 1992 Jan; 45(1):39-47. PubMed ID: 1591920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.